Dr.Ashit Hasmukhlal Shah

Dr. MEHUL SHAH, Dr. SHREYA SHAH, Dr. DEEKSHA THORAT

Abstract

INTRODUCTION: CRVO IS AN CAUSE OF BLINDNESS WOULD LIKE TO DO COMPARATIVE STUDY OF ZYBEV AND AVASTIN ON VISUAL OUTCOME

METHOD: THIS IS A RETROSPECTIVE ANALYSIS OF A COHORT DURING LAST FIVE YEARS AT TERTIARY EYE CARE CENTER. ALL EYES WERE TREATED WITH MEDICAL AND LASER THERAPY. CREATION OF FORMAT AND RETRIVAL OF DATA FROM EMR AND ANALYSED WITH SPSS 22. DESCRIPTIVE AND CROSS TRBULATION METHOD USED FOR ANALYSES. P VALUE <0.05 CONSIDERED STASTICALLY SIGNIFICANT. RESULT: OUR COHORT INCLUDED 105 EYES OUT OF WHICH 66.7%,33.3 % M:F.MEAN AGE 55.9 YEARS.OUT OF WHICH 55.2 % RE, 44.8 %LE OUT OF OUR COHORT22.5 % HYPERTENSIVE,13.3 % DIABETICS AND 4.1 % HAVING OTHER SYSTEMIC DISEASES REMAINING IDEOPATHIC, WHEN WE COMPARED VISUAL OUTCOME AMONGST AVASTIN AND ZYBEV GROUP WE DID NOT FIND SIGNIFICANT DIFFERENCE. (P=0.24) CONCLUSION: WE DID NOT FIND ANY SIGNIFICANT DIFERENCE BETWEEN AVASTIN AND ZYBEV REATED PATIENTS ON VISUAL OUTCOME FOLLOWING MANAGEMENT OF CRVO [advanced_iframe src="https://view.officeapps.live.com/op/embed.aspx?src=https://aiosproceedings.s3.ap-southeast-1.amazonaws.com/2021/E-Poster/FP367.pptx" width="100%" height="608"]